Assertio Acquired by Zydus Lifesciences | Healthcare M&A Deal

Zydus Lifesciences has acquired Assertio, a healthcare services other business in the United States, for $166 million. Assertio provides healthcare services and related offerings that support patient care and commercial execution in the U.S. market, strengthening Zydus Lifesciences acquisitions in healthcare M&A. The strategic acquisition fits Zydus Lifesciences acquisitions strategy as a strategic acquisition and other acquisition within healthcare services other. The announced deal is valued at over $100M and is structured as an other deal, with terms and closing timing not specified.